PMID- 26040706 OWN - NLM STAT- MEDLINE DCOM- 20170418 LR - 20170418 IS - 1753-0407 (Electronic) IS - 1753-0407 (Linking) VI - 8 IP - 4 DP - 2016 Jul TI - Hospitalization and 1-year all-cause mortality in type 2 diabetic patients with chronic kidney disease at Stages 1 and 2: Effect of mild anemia. PG - 502-7 LID - 10.1111/1753-0407.12318 [doi] AB - BACKGROUND: The effect of anemia in advanced chronic kidney disease (CKD) on morbidity and mortality is known. The aim of the present study was to assess the effect of mild anemia on hospitalization and 1-year all-cause mortality in type 2 diabetes mellitus (T2DM) patients with Stage 1 and 2 CKD. METHODS: Hospitalized T2DM patients (n = 307) with a glomerular filtration rate >/= 60 mL/min per 1.73 m(2) and urinary albumin excretion > 30 mg/24 h (Stage 1 and 2 CKD) were enrolled in the study and divided into two groups based on hemoglobin (Hb) concentrations: those with (mean [ +/- SD] Hb 10.7 +/- 0.7 g/dL) and without (mean Hb 13.3 +/- 1.28 g/dL) anemia. RESULTS: There was no significant difference between patients with and without anemia in terms of age, gender, body mass index, HbA1c, and cardiovascular diseases. The mean length of hospitalization of the 130 anemic and 177 non-anemic patients was 4.3 +/- 3.5 and 3.5 +/- 1.9 days, respectively (P < 0.001). Twelve anemic patients died within 1 year, compared with three patients without anemia (9.2% vs 1.7%, respectively; P = 0.002). After adjusting for confounding variables, multivariate Cox regression analysis revealed that mild anemia was significantly associated with 1-year all-cause mortality (hazard ratio 2.15, 95% confidence interval 1.92-2.54; P = 0.033). CONCLUSIONS: Mild anemia may increase the length of hospitalization and was associated with 1-year all-cause mortality among hospitalized T2DM patients with Stage 1 and 2 CKD. CI - (c) 2015 Ruijin Hospital, Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd. FAU - Nseir, William AU - Nseir W AD - Intenal Medicine Department, Holy Family Hospital, Nazareth, Israel. AD - Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel. FAU - Artul, Suheil AU - Artul S AD - Division of Internal Medicine, EMMS, The Nazareth Hospital, Nazareth, Israel. AD - Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel. FAU - Nasrallah, Najib AU - Nasrallah N AD - Division of Internal Medicine, EMMS, The Nazareth Hospital, Nazareth, Israel. FAU - Mograbi, Julnar AU - Mograbi J AD - Intenal Medicine Department, Holy Family Hospital, Nazareth, Israel. FAU - Mahamid, Mahmud AU - Mahamid M AD - Intenal Medicine Department, Holy Family Hospital, Nazareth, Israel. AD - Faculty of Medicine in the Galilee, Bar-Ilan University, Safed, Israel. LA - eng PT - Journal Article DEP - 20150730 PL - Australia TA - J Diabetes JT - Journal of diabetes JID - 101504326 SB - IM MH - Aged MH - Albuminuria/urine MH - Anemia/*complications/pathology MH - Cardiovascular Diseases/complications MH - Cause of Death MH - Diabetes Mellitus, Type 2/*complications/mortality MH - Female MH - Glomerular Filtration Rate MH - Hospitalization/*statistics & numerical data MH - Humans MH - Kaplan-Meier Estimate MH - Length of Stay/statistics & numerical data MH - Male MH - Middle Aged MH - Proportional Hazards Models MH - Renal Insufficiency, Chronic/*complications/pathology MH - Risk Factors MH - Severity of Illness Index MH - Survival Rate MH - Time Factors OTO - NOTNLM OT - 1-year all-cause mortality OT - 1年全因死亡率 OT - 1期与2期CKD OT - anemia OT - diabetes mellitus OT - length of hospitalization OT - stage 1 and 2 CKD OT - 住院时间 OT - 糖尿病 OT - 贫血 EDAT- 2015/06/05 06:00 MHDA- 2017/04/19 06:00 CRDT- 2015/06/05 06:00 PHST- 2015/03/24 00:00 [received] PHST- 2015/05/08 00:00 [revised] PHST- 2015/05/31 00:00 [accepted] PHST- 2015/06/05 06:00 [entrez] PHST- 2015/06/05 06:00 [pubmed] PHST- 2017/04/19 06:00 [medline] AID - 10.1111/1753-0407.12318 [doi] PST - ppublish SO - J Diabetes. 2016 Jul;8(4):502-7. doi: 10.1111/1753-0407.12318. Epub 2015 Jul 30.